A61K 47/6921
The form being a particulate, a powder, an adsorbate, a bead or
Official title: {the form being a particulate, a powder, an adsorbate, a bead or a sphere}
A61K47/6921 (The form being a particulate, a powder, an adsorbate, a bead or) appears on 2,596 US grants and 4,973 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,596
- Published applications
- 4,973
- Assignees
- 1,742
- Inventors
- 9,283
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 14 | 0 |
| 1994 | 11 | 0 |
| 1995 | 22 | 0 |
| 1996 | 29 | 0 |
| 1997 | 27 | 0 |
| 1998 | 27 | 0 |
| 1999 | 22 | 0 |
| 2000 | 25 | 0 |
| 2001 | 19 | 6 |
| 2002 | 28 | 44 |
| 2003 | 27 | 53 |
| 2004 | 15 | 54 |
| 2005 | 11 | 61 |
| 2006 | 21 | 72 |
| 2007 | 17 | 67 |
| 2008 | 15 | 74 |
| 2009 | 27 | 98 |
| 2010 | 22 | 148 |
| 2011 | 41 | 152 |
| 2012 | 64 | 151 |
| 2013 | 89 | 176 |
| 2014 | 93 | 213 |
| 2015 | 119 | 215 |
| 2016 | 140 | 233 |
| 2017 | 145 | 256 |
| 2018 | 139 | 294 |
| 2019 | 184 | 294 |
| 2020 | 191 | 301 |
| 2021 | 175 | 386 |
| 2022 | 155 | 381 |
| 2023 | 183 | 340 |
| 2024 | 182 | 343 |
| 2025 | 192 | 299 |
| 2026 | 121 | 262 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Therapeutic carbon nanomaterial H2S oxidants for biological polysulfide synthesis6 Oct 2026US 12,752,017 B2The Texas A&M University System
- Method for treating tumours by capturing copper and/or iron6 Oct 2026US 12,752,018 B2Centre National De La Recherche Scentifique (Cnrs)
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- Cobalt-porphyrin complexes for the inactivation of the biological activity of opioids15 Sep 2026US 12,734,146 B2The Government of the United States of America, as represented by the Secretary of the Navy
- Treatment and/or diagnosis of a cancer type characterized by expressing zinc transporter ZIP415 Sep 2026US 12,734,245 B2Universitat Pompeu Fabra
- Nanoparticles for photoimmune therapy comprising photosensitizer and adjuvant, and usage thereof8 Oct 2026US 2026/0306632 A1Korea Institute of Science and Technology
- Thrombin sensitive platelet like particles8 Oct 2026US 2026/0306660 A1North Carolina State University
- Trimetazidine solid phases1 Oct 2026US 2026/0294896 A1Les Laboratoires Servier
- Broad-spectrum antibiotic hybrids for the treatment of multi-drug resistant infections1 Oct 2026US 2026/0295059 A1Monash University
- Nucleic acid-peptide-nucleic acid conjugate molecules and methods of making the same1 Oct 2026US 2026/0295069 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers896US 5,410,016 ABoard of Regents, The University of Texas System · 1995
- Biodegradable injectable nanoparticles724US 5,543,158 AMassachusetts Institute of Technology · 1996
- Gels for encapsulation of biological materials587US 5,858,746 ABoard of Regents, The University of Texas System · 1999